Palisade Bio (PALI) FCF Margin (QoQ) (2011 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -2.72 Mn |
| Sep 30, 2020 | -778,516.00 |
| Jun 30, 2020 | 93,275.00 |
| Mar 31, 2020 | 5.41 Mn |
| Dec 31, 2019 | -606,768.00 |
| Sep 30, 2019 | -5.51 Mn |
| Jun 30, 2019 | 4.58 Mn |
| Mar 31, 2019 | -31,500.00 |
| Dec 31, 2018 | 23,712.00 |
| Sep 30, 2018 | -6.56 Mn |
| Jun 30, 2018 | 7.29 Mn |
| Mar 31, 2018 | -7.30 Mn |
| Dec 31, 2017 | 13.21 Mn |
| Sep 30, 2017 | 188,428.00 |
| Jun 30, 2017 | 4.26 Mn |
| Mar 31, 2017 | -13.08 Mn |
| Dec 31, 2016 | 13.24 Mn |
| Sep 30, 2016 | -3.28 Mn |
| Jun 30, 2016 | -609,496.00 |
| Mar 31, 2016 | 1.78 Mn |
| Dec 31, 2015 | 6.37 Mn |
| Sep 30, 2015 | -2.62 Mn |
| Jun 30, 2015 | -3.30 Mn |
| Mar 31, 2015 | -8.70 Mn |
| Dec 31, 2014 | -1.28 Mn |
| Sep 30, 2014 | -1.36 Mn |
| Jun 30, 2014 | 1.88 Mn |
| Mar 31, 2014 | 3.15 Mn |
| Dec 31, 2013 | -501,736.00 |
| Sep 30, 2013 | 4.03 Mn |
| Jun 30, 2013 | -13.21 Mn |
| Mar 31, 2013 | 9.86 Mn |
| Dec 31, 2012 | -10.03 Mn |
| Sep 30, 2012 | 232,775.00 |
| Jun 30, 2012 | -181,502.00 |
| Mar 31, 2012 | -72,046.00 |
| Dec 31, 2011 | 113,503.00 |